CIBC Asset Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.08M Sell
10,148
-38,045
-79% -$4.61M ﹤0.01% 719
2026
Q1
$7.88M Sell
48,193
-270
-0.6% -$41.5K 0.02% 415
2025
Q4
$8.43M Buy
48,463
+43,686
+915% +$7.97M 0.02% 393
2025
Q3
$688K Hold
4,777
﹤0.01% 725
2025
Q2
$481K Hold
4,777
﹤0.01% 769
2025
Q1
$364K Buy
4,777
+92
+2% +$7.04K ﹤0.01% 804
2024
Q4
$323K Buy
4,685
+247
+6% +$17.8K ﹤0.01% 858
2024
Q3
$324K Buy
4,438
+149
+3% +$11K ﹤0.01% 849
2024
Q2
$287K Buy
+4,289
New +$166K ﹤0.01% 853

Other funds holding INSM

CIBC Asset Management's INSM Position: Q2 2026 in Review

CIBC Asset Management reduced its Insmed (INSM) stake by 79% in Q2 2026, selling an estimated $4.61M and leaving 10,148 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #719.

CIBC Asset Management first reported a position in INSM in Q2 2024 and has held it in 9 quarters since. The position peaked at $8.43M in Q4 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • CIBC Asset Management held 10,148 shares of Insmed worth $1.08M as of Q2 2026.
  • CIBC Asset Management sold 38,045 Insmed shares in Q2 2026, an estimated $4.61M.
  • Insmed made up ﹤0.01% of CIBC Asset Management's portfolio in Q2 2026, its #719 holding.
  • CIBC Asset Management first reported a position in Insmed in Q2 2024 and has held it in 9 quarters since.
  • CIBC Asset Management's Insmed position peaked at $8.43M in Q4 2025.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on CIBC Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.